PLoS ONE (Jan 2014)

Characterization of stem-like cells in mucoepidermoid tracheal paediatric tumor.

  • Mei Ling Lim,
  • Brandon Nick Sern Ooi,
  • Philipp Jungebluth,
  • Sebastian Sjöqvist,
  • Isabell Hultman,
  • Greg Lemon,
  • Ylva Gustafsson,
  • Jurate Asmundsson,
  • Silvia Baiguera,
  • Iyadh Douagi,
  • Irina Gilevich,
  • Alina Popova,
  • Johannes Cornelius Haag,
  • Antonio Beltrán Rodríguez,
  • Jianri Lim,
  • Agne Liedén,
  • Magnus Nordenskjöld,
  • Evren Alici,
  • Duncan Baker,
  • Christian Unger,
  • Tom Luedde,
  • Ivan Vassiliev,
  • Jose Inzunza,
  • Lars Ahrlund-Richter,
  • Paolo Macchiarini

DOI
https://doi.org/10.1371/journal.pone.0107712
Journal volume & issue
Vol. 9, no. 9
p. e107712

Abstract

Read online

Stem cells contribute to regeneration of tissues and organs. Cells with stem cell-like properties have been identified in tumors from a variety of origins, but to our knowledge there are yet no reports on tumor-related stem cells in the human upper respiratory tract. In the present study, we show that a tracheal mucoepidermoid tumor biopsy obtained from a 6 year-old patient contained a subpopulation of cells with morphology, clonogenicity and surface markers that overlapped with bone marrow mesenchymal stromal cells (BM-MSCs). These cells, designated as MEi (mesenchymal stem cell-like mucoepidermoid tumor) cells, could be differentiated towards mesenchymal lineages both with and without induction, and formed spheroids in vitro. The MEi cells shared several multipotent characteristics with BM-MSCs. However, they displayed differences to BM-MSCs in growth kinectics and gene expression profiles relating to cancer pathways and tube development. Despite this, the MEi cells did not possess in vivo tumor-initiating capacity, as proven by the absence of growth in situ after localized injection in immunocompromised mice. Our results provide an initial characterization of benign tracheal cancer-derived niche cells. We believe that this report could be of importance to further understand tracheal cancer initiation and progression as well as therapeutic development.